Acadia Healthcare Company short interest was 37.17% of the float on April 15th, according to new data we received from Benzinga. Short interest totaled 22,137,933 shares, which was an increase of 0.25% from March 31st.
It is estimated that it would take 7.9 days for short sellers to buy back their shares, with current trading volumes.
Acadia Healthcare Company Hedge Fund Activity
We have seen 151 institutional investors add shares of Acadia Healthcare Company stock to their portfolio, and 157 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SACHEM HEAD CAPITAL MANAGEMENT LP removed 4,215,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $59,810,850
- JEFFERIES FINANCIAL GROUP INC. added 3,379,813 shares (+inf%) to their portfolio in Q4 2025, for an estimated $47,959,546
- DEERFIELD MANAGEMENT COMPANY, L.P. added 3,331,000 shares (+280.2%) to their portfolio in Q4 2025, for an estimated $47,266,890
- DME CAPITAL MANAGEMENT, LP added 2,478,493 shares (+150.9%) to their portfolio in Q4 2025, for an estimated $35,169,815
- UBS GROUP AG removed 2,358,607 shares (-54.4%) from their portfolio in Q4 2025, for an estimated $33,468,633
- WELLINGTON MANAGEMENT GROUP LLP added 2,350,760 shares (+24.9%) to their portfolio in Q4 2025, for an estimated $33,357,284
- P2 CAPITAL PARTNERS, LLC removed 2,337,188 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $33,164,697
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
Acadia Healthcare Company Analyst Ratings
Wall Street analysts have issued reports on $ACHC in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keybanc issued a "Overweight" rating on 11/18/2025
- RBC Capital issued a "Outperform" rating on 11/12/2025
- Guggenheim issued a "Buy" rating on 11/10/2025
- UBS issued a "Buy" rating on 11/07/2025
To track analyst ratings and price targets for Acadia Healthcare Company, check out Quiver Quantitative's $ACHC forecast page.
Acadia Healthcare Company Price Targets
Multiple analysts have issued price targets for $ACHC recently. We have seen 13 analysts offer price targets for $ACHC in the last 6 months, with a median target of $25.0.
Here are some recent targets:
- Jason Cassorla from Guggenheim set a target price of $31.0 on 05/04/2026
- Ben Hendrix from RBC Capital set a target price of $31.0 on 05/04/2026
- Sarah James from Cantor Fitzgerald set a target price of $30.0 on 05/01/2026
- Andrew Mok from Barclays set a target price of $25.0 on 05/01/2026
- Ryan Langston from TD Cowen set a target price of $30.0 on 04/28/2026
- A.J. Rice from UBS set a target price of $31.0 on 04/17/2026
- Whit Mayo from Leerink Partners set a target price of $22.0 on 02/26/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
